Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

An innovative in situ method of creating hybrid dendrimer nano-assembly: An efficient next generation dendritic platform for drug delivery.

Singh MK, Kuncha M, Nayak VL, Sarma AVS, Kumar MJM, Chauhan AS, Sistla R.

Nanomedicine. 2019 Jun 24;21:102043. doi: 10.1016/j.nano.2019.102043. [Epub ahead of print]

PMID:
31247312
2.

Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.

Sadekar S, Thiagarajan G, Bartlett K, Hubbard D, Ray A, McGill LD, Ghandehari H.

Int J Pharm. 2013 Nov 1;456(1):175-85. doi: 10.1016/j.ijpharm.2013.07.071. Epub 2013 Aug 8.

3.

Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide.

Singh MK, Pooja D, Kulhari H, Jain SK, Sistla R, Chauhan AS.

Eur J Pharm Sci. 2017 Jan 1;96:84-92. doi: 10.1016/j.ejps.2016.09.005. Epub 2016 Sep 8.

PMID:
27614111
4.

Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.

Jain V, Maiti PK, Bharatam PV.

J Chem Phys. 2016 Sep 28;145(12):124902.

PMID:
27782646
5.

Aqueous poly(amidoamine) dendrimer G3 and G4 generations with several interior cores at pHs 5 and 7: a molecular dynamics simulation study.

Kavyani S, Amjad-Iranagh S, Modarress H.

J Phys Chem B. 2014 Mar 27;118(12):3257-66. doi: 10.1021/jp409195c. Epub 2014 Mar 12.

PMID:
24588382
6.

Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.

Parsian M, Mutlu P, Yalcin S, Tezcaner A, Gunduz U.

Int J Pharm. 2016 Dec 30;515(1-2):104-113. doi: 10.1016/j.ijpharm.2016.10.015. Epub 2016 Oct 7.

PMID:
27725272
8.

Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.

Uram Ł, Szuster M, Filipowicz A, Zaręba M, Wałajtys-Rode E, Wołowiec S.

Bioorg Med Chem. 2017 Jan 15;25(2):706-713. doi: 10.1016/j.bmc.2016.11.047. Epub 2016 Nov 25.

PMID:
27919613
9.

In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.

Oddone N, Lecot N, Fernández M, Rodriguez-Haralambides A, Cabral P, Cerecetto H, Benech JC.

J Nanobiotechnology. 2016 Jun 13;14(1):45. doi: 10.1186/s12951-016-0197-6.

10.

Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.

Gupta L, Sharma AK, Gothwal A, Khan MS, Khinchi MP, Qayum A, Singh SK, Gupta U.

Int J Pharm. 2017 Aug 7;528(1-2):88-99. doi: 10.1016/j.ijpharm.2017.04.073. Epub 2017 May 19.

PMID:
28533175
11.

Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.

Souza JG, Dias K, Silva SA, de Rezende LC, Rocha EM, Emery FS, Lopez RF.

J Control Release. 2015 Feb 28;200:115-24. doi: 10.1016/j.jconrel.2014.12.037. Epub 2014 Dec 29.

PMID:
25553828
12.
13.

Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.

Gu Z, Wang M, Fang Q, Zheng H, Wu F, Lin D, Xu Y, Jin Y.

Drug Dev Ind Pharm. 2015 May;41(5):812-8. doi: 10.3109/03639045.2014.908899. Epub 2014 Apr 18.

PMID:
24745851
14.

Study of the interactions of PAMAM G3-NH2 and G3-OH dendrimers with 5-fluorouracil in aqueous solutions.

Buczkowski A, Waliszewski D, Urbaniak P, Palecz B.

Int J Pharm. 2016 May 30;505(1-2):1-13. doi: 10.1016/j.ijpharm.2016.03.061. Epub 2016 Mar 31.

PMID:
27039147
15.

All-atomistic molecular dynamics (AA-MD) studies and pharmacokinetic performance of PAMAM-dendrimer-furosemide delivery systems.

Otto DP, de Villiers MM.

Int J Pharm. 2018 Aug 25;547(1-2):545-555. doi: 10.1016/j.ijpharm.2018.06.033. Epub 2018 Jun 13.

PMID:
29908331
16.

Dendritic chelating agents. 1. Cu(II) binding to ethylene diamine core poly(amidoamine) dendrimers in aqueous solutions.

Diallo MS, Christie S, Swaminathan P, Balogh L, Shi X, Um W, Papelis C, Goddard WA 3rd, Johnson JH Jr.

Langmuir. 2004 Mar 30;20(7):2640-51.

PMID:
15835132
17.

Dendrimers for Drug Delivery.

Chauhan AS.

Molecules. 2018 Apr 18;23(4). pii: E938. doi: 10.3390/molecules23040938. Review.

18.

Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.

Martínez-Muñoz A, Bello M, Romero-Castro A, Rodríguez-Fonseca RA, Rodrigues J, Sánchez-Espinosa VA, Correa-Basurto J.

J Mol Graph Model. 2017 Sep;76:330-341. doi: 10.1016/j.jmgm.2017.07.017. Epub 2017 Jul 19.

PMID:
28759825
19.

Mix and Match: Coassembly of Amphiphilic Dendrimers and Phospholipids Creates Robust, Modular, and Controllable Interfaces.

Hinman SS, Ruiz CJ, Cao Y, Ma MC, Tang J, Laurini E, Posocco P, Giorgio S, Pricl S, Peng L, Cheng Q.

ACS Appl Mater Interfaces. 2017 Jan 11;9(1):1029-1035. doi: 10.1021/acsami.6b11556. Epub 2016 Dec 22.

20.

The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin.

Ciolkowski M, Rozanek M, Bryszewska M, Klajnert B.

Biochim Biophys Acta. 2013 Oct;1834(10):1982-7. doi: 10.1016/j.bbapap.2013.06.020. Epub 2013 Jul 10.

PMID:
23851144

Supplemental Content

Support Center